Table 7. Mortality analysis stratified by treatment initiation of positive cases, age group, sex and past history of treatment.
| Variables | Pretreatment mortality, n (%) | On-treatment mortality, n (%) | ||||
|---|---|---|---|---|---|---|
| Rif Sen | Rif Res | Total | Rif Sen | Rif Res | Total | |
| Total | 60 (2.0%) | 18 (6.1%) | 78 (2.3%) | 88 (3.2%) | 24 (9.3%) | 112 (3.7%) |
| Age Group | ||||||
| 0–4 | 32 (5.0%) | 6 (14.3%) | 38 (5.6%) | 33 (6.3%) | 8 (25.8%) | 41 (7.4%) |
| 5–9 | 13 (1.9%) | 4 (2.1%) | 17 (1.9%) | 23 (3.7%) | 5 (3.0%) | 28 (3.5%) |
| 10–14 | 15 (0.9%) | 8 (12.1%) | 23 (1.3%) | 32 (2.0%) | 11 (19.3%) | 43 (2.6%) |
| Sex | ||||||
| F | 38 (2.0%) | 11 (6.3%) | 49 (2.4%) | 51 (3.0%) | 13 (8.3%) | 64 (3.5%) |
| M | 22 (1.9%) | 7 (5.9%) | 29 (2.2%) | 37 (3.5%) | 11 (11.0%) | 48 (4.2%) |
| Past history | ||||||
| No | 58 (2.2%) | 18 (9.0%) | 76 (2.7%) | 71 (3.1%) | 18 (11.1%) | 89 (3.6%) |
| Yes | 2 (0.5%) | 0 | 2 (0.4%) | 17 (4.0%) | 6 (6.3%) | 23 (4.4%) |